Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease

Daniela Fluxá, Jorge Segovia, Matías Florenzano, Jessica Salinas, Lilian Flores, Daniela Simian, Rodrigo P. Quera

Research output: Contribution to journalArticlepeer-review

Abstract

There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.

Translated title of the contributionPneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease
Original languageSpanish
Pages (from-to)518-519
Number of pages2
JournalRevista Chilena de Infectologia
Volume34
Issue number5
DOIs
StatePublished - Oct 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2018, Sociedad Chilena de Infectologia. All rights reserved.

Fingerprint

Dive into the research topics of 'Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease'. Together they form a unique fingerprint.

Cite this